Report Detail
Global (United States, European Union and China) Growth Factors (Blood and Tissue) Market Research Report 2019-2025
- RnM3695387 |
- 26 August, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.
In 2019, the market size of Growth Factors (Blood and Tissue) is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Growth Factors (Blood and Tissue).
This report studies the global market size of Growth Factors (Blood and Tissue), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Growth Factors (Blood and Tissue) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)
Market Segment by Product Type
Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors
Market Segment by Application
Hospital
Research lab
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Growth Factors (Blood and Tissue) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Growth Factors (Blood and Tissue) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Growth Factors (Blood and Tissue) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Growth Factors (Blood and Tissue) Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
- 1.3.3 Tissue Growth Factors
- 1.4 Market Segment by Application
- 1.4.1 Global Growth Factors (Blood and Tissue) Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Research lab
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Growth Factors (Blood and Tissue) Market Size
- 2.1.1 Global Growth Factors (Blood and Tissue) Revenue 2014-2025
- 2.1.2 Global Growth Factors (Blood and Tissue) Sales 2014-2025
- 2.2 Growth Factors (Blood and Tissue) Growth Rate by Regions
- 2.2.1 Global Growth Factors (Blood and Tissue) Sales by Regions 2014-2019
- 2.2.2 Global Growth Factors (Blood and Tissue) Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Growth Factors (Blood and Tissue) Sales by Manufacturers
- 3.1.1 Growth Factors (Blood and Tissue) Sales by Manufacturers 2014-2019
- 3.1.2 Growth Factors (Blood and Tissue) Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Growth Factors (Blood and Tissue) Revenue by Manufacturers (2014-2019)
- 3.2.2 Growth Factors (Blood and Tissue) Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Growth Factors (Blood and Tissue) Market Concentration Ratio (CR5 and HHI)
- 3.3 Growth Factors (Blood and Tissue) Price by Manufacturers
- 3.4 Key Manufacturers Growth Factors (Blood and Tissue) Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Growth Factors (Blood and Tissue) Market
- 3.6 Key Manufacturers Growth Factors (Blood and Tissue) Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) Sales and Revenue (2014-2019)
- 4.1.2 Tissue Growth Factors Sales and Revenue (2014-2019)
- 4.2 Global Growth Factors (Blood and Tissue) Sales Market Share by Type
- 4.3 Global Growth Factors (Blood and Tissue) Revenue Market Share by Type
- 4.4 Growth Factors (Blood and Tissue) Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Growth Factors (Blood and Tissue) Sales by Application
6 United States
- 6.1 United States Growth Factors (Blood and Tissue) Breakdown Data by Company
- 6.2 United States Growth Factors (Blood and Tissue) Breakdown Data by Type
- 6.3 United States Growth Factors (Blood and Tissue) Breakdown Data by Application
7 European Union
- 7.1 European Union Growth Factors (Blood and Tissue) Breakdown Data by Company
- 7.2 European Union Growth Factors (Blood and Tissue) Breakdown Data by Type
- 7.3 European Union Growth Factors (Blood and Tissue) Breakdown Data by Application
8 China
- 8.1 China Growth Factors (Blood and Tissue) Breakdown Data by Company
- 8.2 China Growth Factors (Blood and Tissue) Breakdown Data by Type
- 8.3 China Growth Factors (Blood and Tissue) Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Company
- 9.2 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Type
- 9.3 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Application
- 9.4 Rest of World Growth Factors (Blood and Tissue) Breakdown Data by Countries
- 9.4.1 Rest of World Growth Factors (Blood and Tissue) Sales by Countries
- 9.4.2 Rest of World Growth Factors (Blood and Tissue) Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Amgen, Inc. (USA)
- 10.1.1 Amgen, Inc. (USA) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.1.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.1.5 Amgen, Inc. (USA) Recent Development
- 10.2 Bayer HealthCare Pharmaceuticals, Inc. (USA)
- 10.2.1 Bayer HealthCare Pharmaceuticals, Inc. (USA) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.2.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.2.5 Bayer HealthCare Pharmaceuticals, Inc. (USA) Recent Development
- 10.3 Biocon Ltd. (India)
- 10.3.1 Biocon Ltd. (India) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.3.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.3.5 Biocon Ltd. (India) Recent Development
- 10.4 Biogen, Inc. (USA)
- 10.4.1 Biogen, Inc. (USA) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.4.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.4.5 Biogen, Inc. (USA) Recent Development
- 10.5 BioMimetic Therapeutics LLC (USA)
- 10.5.1 BioMimetic Therapeutics LLC (USA) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.5.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.5.5 BioMimetic Therapeutics LLC (USA) Recent Development
- 10.6 Biopharm GmbH (Germany)
- 10.6.1 Biopharm GmbH (Germany) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.6.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.6.5 Biopharm GmbH (Germany) Recent Development
- 10.7 Bolder BioTechnology, Inc. (USA)
- 10.7.1 Bolder BioTechnology, Inc. (USA) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.7.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.7.5 Bolder BioTechnology, Inc. (USA) Recent Development
- 10.8 F. Hoffmann-La Roche AG (Switzerland)
- 10.8.1 F. Hoffmann-La Roche AG (Switzerland) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.8.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.8.5 F. Hoffmann-La Roche AG (Switzerland) Recent Development
- 10.9 Chugai Pharmaceutical Co. Ltd. (Japan)
- 10.9.1 Chugai Pharmaceutical Co. Ltd. (Japan) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.9.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.9.5 Chugai Pharmaceutical Co. Ltd. (Japan) Recent Development
- 10.10 Genentech, Inc. (USA)
- 10.10.1 Genentech, Inc. (USA) Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Growth Factors (Blood and Tissue)
- 10.10.4 Growth Factors (Blood and Tissue) Product Introduction
- 10.10.5 Genentech, Inc. (USA) Recent Development
- 10.11 FibroGen, Inc. (USA)
- 10.12 Johnson & Johnson (USA)
- 10.13 Janssen Biotech, Inc. (USA)
- 10.14 Lonza Group (Switzerland)
- 10.15 Merck Serono (Germany)
- 10.16 PeproTech, Inc. (USA)
- 10.17 Reliance GeneMedix Plc (UK)
- 10.18 Sangamo Therapeutics, Inc. (USA)
- 10.19 Sanofi (France)
- 10.20 Scil Proteins GmbH (Germany)
- 10.21 Teva Pharmaceutical Industries Ltd. (Israel)
- 10.22 Wockhardt Ltd. (India)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Growth Factors (Blood and Tissue) Sales Channels
- 11.2.2 Growth Factors (Blood and Tissue) Distributors
- 11.3 Growth Factors (Blood and Tissue) Customers
12 Market Forecast
- 12.1 Global Growth Factors (Blood and Tissue) Sales and Revenue Forecast 2019-2025
- 12.2 Global Growth Factors (Blood and Tissue) Sales Forecast by Type
- 12.3 Global Growth Factors (Blood and Tissue) Sales Forecast by Application
- 12.4 Growth Factors (Blood and Tissue) Forecast by Regions
- 12.4.1 Global Growth Factors (Blood and Tissue) Sales Forecast by Regions 2019-2025
- 12.4.2 Global Growth Factors (Blood and Tissue) Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Growth Factors (Blood and Tissue). Industry analysis & Market Report on Growth Factors (Blood and Tissue) is a syndicated market report, published as Global (United States, European Union and China) Growth Factors (Blood and Tissue) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Growth Factors (Blood and Tissue) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
